Severe renal complications in chronic myelomonocytic leukemia

Journal of Nephrology

Volumn 21, Issue 4, 2008, Pages 609-614

  Eníquez, Ricardo ^a   Sirvent, Ana E ^a   Marín, Francisca ^a   Pérez, Miguel ^a   Alpera, María R ^b   Amorós, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b Hospital General de EIche   (Spain)

Author keywords

Acute renal failure; Chronic myelomonocytic leukemia; Membranous glomerulonephritis; Mycophenolate mofetil; Nephrotic syndrome; Renal lithiasis

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BICARBONATE; BISOPROLOL; CHLORAMBUCIL; CITRATE POTASSIUM; CLOPIDOGREL; CYCLOSPORIN A; FUROSEMIDE; HYDROXYUREA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANTOPRAZOLE; PREDNISONE; CYCLOSPORIN; DRUG DERIVATIVE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PRODRUG;

ACUTE KIDNEY FAILURE; ADULT; ALKALINIZATION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FLANK PAIN; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; HYPOTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LABORATORY TEST; LEG EDEMA; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONOCYTOSIS; NEPHROLITHIASIS; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PROTEINURIA; SPLENOMEGALY; URETER CATHETERIZATION; URETER STENT; URETER STONE; URINE COLOR; BIOPSY; BONE MARROW; CHRONIC MYELOID LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FOLLOW UP; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY;

BIOPSY; BONE MARROW; CYCLOSPORINE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PRODRUGS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52649095511     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Solal-Celigny P, Desaint B, Herrera A, et al. Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood. 1984;63:634-638.
2. Vardiman JW, Pierre R, Bain B, et al. Chronic myelomonocytic leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:49-52.
3. Morschhauser F, Wattel E, Pagniez D, et al. Glomerular injury in chronic myelomonocytic leukemia. Leuk Lymphoma. 1995;18:479-483.
4. Saitoh T, Murakami H, Uchiumi H, et al. Myelodysplastic syndromes with nephrotic syndrome. Am J Hematol. 1999;60:200-204.
5. Robinson GT, Sundaram KR, Dilly SA, Bevan DH, Andrews PA. Renal failure in a patient with chronic myelomonocytic leukaemia. Nephrol Dial Transplant. 1997;12:1500-1502.
6. Hope-Gill B, Goepel JR, Collin RC. Obstructive uropathy associated with myelomonocytic infiltration of the prostate. J Clin Pathol. 1998;51:340-342.
7. Yen TH, Chang CT, Ng KK, Wu MS. Bilateral renal infarction in chronic myelomonocytic leukemia on blast crisis. Ren Fail. 2003;25:1029-1035.
8. Steensma DP, Tefferi A, Li CY. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome. Leuk Res. 2003;27:775-782.
9. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma. 2002;43:2083-2092.
10. Aslangul-Castier E, Papo T, Amoura Z, et al. Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia. Ann Rheum Dis. 2000;59:390-393.
11. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol. 1995;91:403-408.
12. Paydas S, Paydas S, Tuncer I, Zorludemir S, Gonlusen G. A case with membranous glomerulonephritis and myelodysplastic syndrome. Nephron. 1992;62:231-232.
13. Doukkali O, Tarrass F, Medkouri G, et al. Glomérulonéphrite extramembraneuse et syndrome myélodysplasique. Néphrologie. 2004;25:59-61.
14. Bogdanovic R, Kuzmanovic M, Markovic-Lipkovski J, et al. Glomerular involvement in myelodysplastic syndromes. Pediatr Nephrol. 2001;16:1053-1057.
15. Yahata N, Kawanishi Y, Okabe S, et al. Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia. Am J Nephrol. 2000;20:402-407.
16. Arnold TM, Reuter JP, Delman BS, Shanholtz CB. Use of single-dose rasburicase in an obese female. Ann Pharmacother. 2004;38:1428-1431.
17. Otrock ZK, Taher AT, Mahfouz RA, Makarem JA, Shamseddine AI. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia. Am J Hematol. 2006;8:220-221.
18. Bane AL, Enright H, Sweeney EG. Chronic myelomonocytic leukemia revealed by uncontrollable hematuria. Arch Pathol Lab Med. 2001;125:657-659.
19. Hsu HH, Chan YL, Huang CC. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: Clinical features and therapeutic approach. J Nephrol. 2004;17:50-56.
20. Pais VM Jr, Lowe G, Lallas GD, Preminger GM, Assimos DG. Xanthine urolithiasis. Urology. 2006;67:1084.e9-1084.e11.
21. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386-392.
22. Cantarell MC, Capdevila L, Morlans M, Piera L. Uric acid calculus in renal transplant patients treated with cyclosporine. Clin Nephrol. 1991;35:288.
23. Norlén BJ, Hellström M, Nisa M, Robertson WG. Uric acid stone formation in a patient after kidney transplantation-metabolic and therapeutic considerations. Scand J Urol Nephrol. 1995;29:335-337.
24. Hwang MT, Goldfarb DS. Uric acid stones following hepatic transplantation. Urol Res. 2004;32:423-426.
25. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol. 2000;11:974-979.